✦ LIBER ✦

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

✍ Scribed by Jansen, L.; Takkenberg, R.B.; de Niet, A.; Zaaijer, H.L.; Weegink, C.J.; Terpstra, V.; Dijkgraaf, M.G.W.; Molenkamp, R.; Janssen, P.L.M.; Koot, M.; Rijckborst, V.; Janssen, H.L.A.; Beld, M.G.H.M.; Reesink, H.W.

Book ID: 122537818
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60755-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 BASELINE HBsAg LEVEL PREDICT HBsAg LO

15 BASELINE HBsAg LEVEL PREDICT HBsAg LOSS IN CHRONIC HEPATITIS B PATIENTS TREATED WITH A COMBINATION OF PEGINTERFERON ALFA-2A AND ADEFOVIR: AN INTERIM ANALYSIS

✍ B. Takkenberg; H. Zaaijer; C. Weegink; V. Terpstra; M. Dijkgraaf; P. Jansen; H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

1027 INTRAHEPATIC HBSAG PREDICTS TREATME

1027 INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR; AN INTERIM ANALYSIS

✍ Takkenberg, B.; De Niet, A.; Terpstra, V.; Zaaijer, H.; Weegink, C.; Koot, M.; D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

917 ON-TREATMENT MONITORING OF HBsAg LEV

917 ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B

✍ G.K.K. Lau; P. Marcellin; M. Brunetto; T. Piratvisuth; H.-P. Kapprell; D. Messin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

527 SUSTAINED HCV CLEARANCE AND INCREASE

527 SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP

✍ C.-J. Liu; W.-L. Chuang; C.-M. Lee; M.-L. Yu; S.-N. Lu; S.-S. Wu; L.-Y. Liao; C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

924 INCREASING RATES OF HBsAg CLEARANCE

924 INCREASING RATES OF HBsAg CLEARANCE AND SEROCONVERSION IN PATIENTS WITH HBeAg-NEGATIVE DISEASE TREATED WITH PEGINTERFERON ALFA-2A ± LAMIVUDINE: RESULTS OF 5-YEAR POST-TREATMENT FOLLOW UP

✍ P. Marcellin; T. Piratvisuth; M. Brunetto; F. Bonino; G.K.K. Lau; P. Farci; C. Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Use of on-Treatment HBsAg Level and HBeA

Use of on-Treatment HBsAg Level and HBeAg Index Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

✍ Phisalprapa, Pochamana ;Charatcharoenwitthaya, Phunchai ;Chainuvati, Siwaporn P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 570 KB